Related Experiment Video
Updated: Oct 5, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
A rare case of advanced ovarian carcinoma who developed difficulty walking 25 days after treatment with weekly
Y Kikuchi1, H Hiramatsu, H Seto
1Department of Obstetrics and Gynecology, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama 359-8513, Japan. QWL04765@nifty.ne.jp
Abstract:
Although taxol has shown significant activity in advanced ovarian cancer, peripheral neuropathy is likely to become the major dose-limiting toxicity. We describe a case of advanced ovarian carcinoma who developed difficulty walking because of marked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly taxol (80 mg/m(2)x3).
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Drugs that Stabilize Microtubules